AAMU
CBPO

Amundi Asset Management US’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Amundi Asset Management US’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$722K Hold
6,100
– – ﹤0.01% 1291
2020
Q4 		$720K Buy
6,100
+3,400
+126% +$395K ﹤0.01% 1252
2020
Q3 		$300K Hold
2,700
– – ﹤0.01% 1325
2020
Q2 		$276K Hold
2,700
– – ﹤0.01% 1337
2020
Q1 		$291K Hold
2,700
– – ﹤0.01% 1277
2019
Q4 		$314K Hold
2,700
– – ﹤0.01% 1395
2019
Q3 		$309K Buy
2,700
+600
+29% +$59.7K ﹤0.01% 1387
2019
Q2 		$200K Hold
2,100
– – ﹤0.01% 1478
2019
Q1 		$192K Hold
2,100
– – ﹤0.01% 1442
2018
Q4 		$159 Buy
2,100
+933
+80% +$68.7K ﹤0.01% 1423
2018
Q3 		$93K Buy
1,167
+800
+218% +$74.5K ﹤0.01% 1523
2018
Q2 		$36K Sell
367
-13,390
-97% -$1.16M ﹤0.01% 1523
2018
Q1 		$1.11M Sell
13,757
-29,745
-68% -$2.4M ﹤0.01% 1171
2017
Q4 		$3.43M Buy
+43,502
New +$3.62M 0.01% 952
2015
Q1 		– Sell
-5,525
Closed -$371K – 651
2014
Q4 		$371K Buy
+5,525
New +$342K ﹤0.01% 596

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Amundi Asset Management US's CBPO Position: Q1 2021 in Review

Amundi Asset Management US held its China Biologic Products Holdings, Inc. (CBPO) position steady in Q1 2021 at 6,100 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Amundi Asset Management US first reported a position in CBPO in Q4 2014 and has held it in 15 quarters since. The position peaked at $3.43M in Q4 2017. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Amundi Asset Management US held 6,100 shares of China Biologic Products Holdings, Inc. worth $722K as of Q1 2021.
  • Amundi Asset Management US left its China Biologic Products Holdings, Inc. share count unchanged in Q1 2021.
  • China Biologic Products Holdings, Inc. made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1291 holding.
  • Amundi Asset Management US first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and has held it in 15 quarters since.
  • Amundi Asset Management US's China Biologic Products Holdings, Inc. position peaked at $3.43M in Q4 2017.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.